|
3 - 2F
PROMOTION OF CLEANER PRODUCTION IN BEIJING'S PHARMACEUTICAL INDUSTRY
|
1. Project Summary and Relationship to China's Agenda
21
The goals of this project are, i) the implementation of
cleaner production (CP) in representative pharmaceutical
companies in Beijing and, ii) the establishment of an
information base to facilitate, a) the introduction of CP
throughout Beijing's
pharmaceutical industry and b) pilot projects in other areas
and industries. Project activities include: identification of
CP technologies; education and training; setting up
demonstration projects; monitoring and auditing.
The project is based on programme area 12B and is related
to programme areas 12D, 13B, 14C, 18A and 19A in China's Agenda 21.
2. Background
Beijing Municipality has a population of 11 million and
covers an area of 16,800 square kilometres. In 1990, waste
water discharges totalled 837 million tons, and waste gas
emissions 277 billion m(. The major polluting enterprises of
Beijing's pharmaceutical
industry discharged 4.16 million tons waste water out of the
total water consumption of 21.88 million tons. However, the
waste water treatment rate for the pharmaceutical industry is
as low as 0.01% and only 2.67% of treated waste water meets
the state discharge standards. The annual discharges of the
pharmaceutical industry amount to 1,347 tons of COD, 442 tons
of BOD and 152 tons of SS. The pharmaceutical industry is
also a major source of volatile phenol emissions in Beijing,
accounting for 5.7 tons per year. On average, for every RMB
10,000 yuan of output, 70 tons of wastewater and 0.026 tons
of COD are produced. Theses high figures indicate that the
industry has a great potential for the development of CP.
The project initially aims to improve management,
competitiveness and economic efficiency by implementing CP
pilot projects in representative enterprises( including No. 1
Branch of Beijing Pharmaceutical Factory, No. 2
Pharmaceutical Factory, and Beijing Biochemical
Pharmaceutical Factory) that are major users of industrial
water. In so doing, both the main obstacles and the potential
of CP will be ascertained and an information base
established. The experiences of developing CP in the
pharmaceutical industry will contribute to the future
promotion of CP in other industries.
The sustainable development strategy has been determined
by the Chinese Government. This strategy requires two
fundamental transformations in the economic system and the
means of pursuing economic growth. CP is seen by both
Government and industry as central to realising sustainable
development and improving these two fundamental
transformations. CP is an important objective of both the
Ninth Five-Year Plan and Long-term Target of Beijing for the
Year 2010. CP is also a major focus of the implementation of
China's Agenda 21 in
Beijing. Since 1993, CP projects have been implemented in 30
workshops or production lines of 26 enterprises in 14
industries in Beijing. A total of 655 CP options have been
generated by these 26 enterprises, of which 250 primarily
involve improving management, and 217 involve modifications
to equipment and technologies. By the end of 1995, 363 of
these options had been implemented. These implementations
reduced waste water and COD discharges by 1.65 million tons
and 3,201 tons respectively, and saved 366,000 tons of water
and 38.4 million RMB. It is expected that COD discharges will
have been reduced by 3,248 tons with savings of 100 million
RMB after implementation of all options. During the first
three years, 1994-1995, many methods of CP have been proven
in practice, and groups of CP experts have been trained, and
much experience has been accumulated in the dissemination of
CP technologies. A set of practical guidelines is being
developed based on the experience of developing CP in
Beijing. A good foundation has been established for the
implementation of CP in Beijing's
pharmaceutical industry.
The Beijing Municipal Training Centre for Environmental
Protection Technology, as one of the implementing agencies,
has acquired much valuable experience in the development of
CP. In 1995, a Norwegian-Chinese "Transfer
of Know-how Program on Cleaner Production" was
successfully carried out and won the approval of the
enterprises and departments involved. In 1996, the centre
participated in the "Adjustment
of industrial construction and implementation of CP in Benxi
city" program.
3. Objectives
3.1 Long-term Objective
To formulate practical policy for promoting CP in various
industries; to establish standard CP systems in enterprises;
to compile practice guidelines for CP; to improve technical
co-operation and information exchange by implementing CP in
Beijing enterprises.
3.2 Immediate Objectives
- To develop training in, and auditing of, CP; to train 20
CP experts with abundant experience in Beijing's pharmaceutical industry;
- To implement CP demonstration projects, and set up some
model enterprises in the pharmaceutical industry of
Beijing;
- To compile CP practice guidelines for the pharmaceutical
industry;
- To promote co-operation and information exchange on CP.
4. Outputs and Activities
4.1 Training and auditing of CP in the pharmaceutical
industry of Beijing
- To organise three one-week training courses for 40
persons from 5 pharmaceutical enterprises, namely,
Beijing No. 4 Pharmaceutical Factory, Beijing
Pharmaceutical Factory, Beijing No. 2 Pharmaceutical
Factory, Beijing No. 3 Pharmaceutical Factory and Beijing
Biochemical Pharmaceutical Factory;
- To conduct a one-year audit of CP in these 5 factories.
Monitoring Indicators: Organising CP training for 40
persons from 5 pharmaceutical enterprises and compiling audit
reports for these enterprises. 20 technical persons will have
been highly trained in CP in the pharmaceutical industry.
Implementing Agencies: Beijing Municipal Training Centre
for Environmental Protection Technology and 5 involved
pharmaceutical enterprises in co-operation with Beijing
Leader Group Office for the Implementation of China's Agenda 21.
Time Schedule: January 1997 - June 1998
4.2 CP pilot project of vinyl chloride (VC) products in
Beijing Pharmaceutical Factory
- To identify and generate CP options for the VC
production-line based on the CP audit;
- To reduce waste liquid discharges in the process of VC
production by recycling and reusing waste liquid
containing bacteria;
- To reduce air pollution and harm to human health caused
by methyl alcohol, by utilising the cleaner production
technology of 2-step fermentation on VC products and
eliminating the acidification process;
- To reduce solid waste generated during the process of VC
production by the comprehensive utilisation of activated
carbon containing bacteria;
- To analyse environmental and economic results after
implementation of the selected options.
Monitoring Indicator: accomplishment of technical
modifications and the pollution reduction objectives
Implementing Agencies: Beijing pharmaceutical Plant and
Beijing Municipal Training Centre for Environmental
Protection Technology
Time Schedule: October 1997 - October 2000
4.3 CP pilot project in the raw material workshop of
Beijing No. 2 Pharmaceutical Plant
- To identify CP options for the raw materials workshop
based on a CP audit;
- To introduce key techniques and equipment to produce
isoniazid, sulphadimethylthiazole and sulfamidine;
- To identify and implement other CP options;
- To analyse the environmental and social results of the
implemented pilot project.
Monitoring Indicators: accomplishment of technical
modifications and the pollution reduction objectives
Implementing Agencies: Beijing No. 2 Pharmaceutical
Factory and The Beijing Municipal Training Centre for
Environmental Protection Technology
Time Schedule: October 1997 - October 2000
4.4 Dissemination of cleaner production experiences in the
pharmaceutical industry
- To hold an international workshop of 80 participants on
the implementation of CP projects in the pharmaceutical
industry and to investigate the CP situation in foreign
pharmaceutical industries;
- To formulate guidelines for the implementation of CP
suited to circumstances in China, and to establish a
database and management information exchange system for
CP in the pharmaceutical industry;
- To develop a relationship with ICPIC of UNEP in the
interests of information exchange and co-operation on CP;
- To disseminate CP knowledge and experience among other
industries.
Monitoring Indicators: Completion of a report on the
implementation of CP in foreign pharmaceutical industries;
formulation of implementation guidelines for the
pharmaceutical industry; the development of the software for
a CP technical database and information exchange system in
the pharmaceutical industry
Implementing Agency: the Beijing Municipal Training Centre
for Environmental Protection Technology
Time Schedule: October 1997 - April 1999
5. Inputs
5.1 Chinese inputs
Funds primarily to cover: partial costs of domestic CP
training; operating costs of the development of CP; costs of
demonstration projects; development of CP information
exchange system; services and management expenses, etc.
5.2 International inputs Funds to cover the expenses of
inviting CP experts, the acquisition of technology and
equipment of cleaner production in the pharmaceutical
industry, etc.
5.3 Budget
The total capital needed for this project is US$ 7.5
million. The Chinese participants will raise US$ 1.2 million
from domestic sources, while foreign aid and investment will
cover the other US$ 6.3 million.
Table 1. Budget by Item (in million US
dollars)
| Item |
Total |
Chinese Inputs |
International Inputs |
| Subtotal |
Grant |
Loan |
Local
Contribution |
Subtotal |
Grant |
Loan |
Direct
Investment |
Foreign
Experts |
0.15 |
|
|
|
|
0.15 |
0.15 |
|
|
| Training |
0.30 |
0.15 |
0.10 |
|
0.05 |
0.15 |
0.15 |
|
|
Technology
for Pilot
Projects |
1.50 |
|
|
|
|
1.50 |
0.30 |
|
1.20 |
Equipment for Pilot
Projects |
4.80 |
0.80 |
|
0.80 |
|
4.00 |
|
2.00 |
2.00 |
Technology
Dissemination |
0.25 |
0.15 |
0.15 |
|
|
0.10 |
0.10 |
|
|
| Contingency |
0.50 |
0.10 |
|
0.10 |
|
0.40 |
|
0.20 |
0.20 |
| Total |
7.50 |
1.20 |
0.25 |
0.90 |
0.05 |
6.30 |
0.70 |
2.20 |
3.40 |
Table 2. Budget by Output (in million
US dollars)
| Output |
Total |
Chinese Inputs |
International Inputs |
| Subtotal |
Grant |
Loan |
Local
Contribution |
Subtotal |
Grant |
Loan |
Direct
Investment |
| 4.1 |
0.45 |
0.15 |
0.10 |
|
0.05 |
0.30 |
0.30 |
|
|
| 4.2 |
3.35 |
0.45 |
|
0.45 |
|
2.90 |
0.25 |
1.10 |
1.55 |
| 4.3 |
3.45 |
0.45 |
|
0.45 |
|
3.00 |
0.05 |
1.10 |
1.85 |
| 4.4 |
0.25 |
0.15 |
0.15 |
|
|
0.10 |
0.10 |
|
|
| Total |
7.50 |
1.20 |
0.25 |
0.90 |
0.05 |
6.30 |
0.70 |
2.20 |
3.40 |
6. Benefits
Experience of the introduction in CP in Beijing shows that
cost-benefit ratios are generally very high, sometimes
reaching 1:20. It is therefore a good investment in direct
terms. The adoption of CP could bring significant economic
benefits to the whole of Beijing's
pharmaceutical industry.
Experience also shows that the use of CP can reduce a
factory's pollutant
discharges by 10-30%. It is anticipated that the adoption of
CP by the whole of Beijing's
pharmaceutical industry would reduce waste water discharges
by 0.41-1.25 million tons. This would greatly improve the
city's environmental
quality in Beijing city.
7. Risks
The successful implementation of this project faces three
major obstacles:
i) Most managers have little knowledge of ,or confidence
in, CP technologies;
ii) There is insufficient information exchange on CP in
China;
iii) There are insufficient funds available to support the
introduction in enterprises.
These problems should be addressed in the following ways:
i) Comprehensive information on CP should be acquired by
managers through the provision of written materials, meetings
and visits to factories that have adopted CP practices;
ii) A system for collecting, collating and disseminating
the latest developments in CP should be developed;
iii) Funds should be provided to enterprises for their CP
programs. Given that the adoption of CP brings direct
economic benefit to many companies, these funds could often
take the form of revolving credits with steadily increasing
volume.
Text Browser Utilities: |Back| |ACCA21
Home|
|